HIGHLIGHTS
SUMMARY
Polycystic ovary syndrome (PCOS) is a highly heterogeneous disease that presents as an alternative combination of polycystic ovary morphology (PCOM), ovulation disorder, hyperandrogenism, and other metabolic and psychological disorders. The heterogeneity of patients with PCOS has seldom been considered when calculating AMH cutoff values. Although a consensus has not yet been reached, previous studies have indicated an inverse relationship between serum AMH levels and BMIs in women with PCOS and in the general population. The authors aimed to explore the predictive power of AMH in infertile women with PCOS/PCOM and determine the BMI . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.